Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bioatla, Inc. (BCAB)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 46,110,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   BioAtla is a biopharmaceutical company engaged in developing specific and selective antibody-based therapeutics for the treatment of various cancers. Co.'s lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. Co. also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 81,495 83,495 252,735
Total Buy Value $0 $172,540 $177,620 $814,041
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 5 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 207
  Page 6 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Vasquez Christian See Remarks   •       –      –    2022-02-28 4 D $6.48 $1,490 D/D (230) 25,097     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-02-28 4 D $6.48 $18,714 D/D (2,888) 1,309,878     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-01-31 4 D $9.56 $10,994 D/D (1,150) 132,444     -
   Smith Scott Andrew President   •       •      –    2022-01-31 4 D $9.56 $20,850 D/D (2,181) 340,581     -
   Vasquez Christian See Remarks   •       –      –    2022-01-31 4 D $9.56 $2,199 D/D (230) 25,327     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-01-31 4 D $9.56 $32,294 D/D (3,378) 1,312,766     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-01-31 4 D $9.56 $6,281 D/D (657) 90,054     -
   Waldron Richard A Chief Financial Officer   •       –      –    2021-12-31 4 D $19.63 $27,305 D/D (1,391) 133,078     -
   Vasquez Christian See Remarks   •       –      –    2021-12-31 4 D $19.63 $3,808 D/D (194) 25,065     -
   Sievers Eric Chief Medical Officer   •       –      –    2021-12-31 4 D $19.63 $15,606 D/D (795) 90,711     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-12-31 4 D $19.63 $91,613 D/D (4,667) 1,316,144     -
   Smith Scott Andrew President   •       •      –    2021-12-31 4 D $19.63 $56,809 D/D (2,894) 342,762     -
   Sievers Eric Chief Medical Officer   •       –      –    2021-12-02 4 S $21.74 $17,839 D/D (820) 91,506     -
   Smith Scott Andrew President   •       •      –    2021-12-02 4 S $21.74 $64,918 D/D (2,984) 345,656     -
   Vasquez Christian See Remarks   •       –      –    2021-12-02 4 S $21.74 $4,351 D/D (200) 25,259     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-12-02 4 S $21.74 $104,666 D/D (4,811) 1,320,811     -
   Waldron Richard A Chief Financial Officer   •       –      –    2021-12-02 4 S $21.74 $31,198 D/D (1,434) 134,469     -
   Sievers Eric Chief Medical Officer   •       –      –    2021-12-01 4 S $22.19 $3,985 D/D (173) 92,326     -
   Smith Scott Andrew President   •       •      –    2021-12-01 4 S $22.19 $14,466 D/D (628) 348,640     -
   Vasquez Christian See Remarks   •       –      –    2021-12-01 4 S $22.19 $23,289 D/D (1,011) 25,459     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-12-01 4 S $22.19 $560,226 D/D (24,321) 1,325,622     -
   Waldron Richard A Chief Financial Officer   •       –      –    2021-12-01 4 S $22.19 $166,910 D/D (7,246) 135,903     -
   Sievers Eric Chief Medical Officer   •       –      –    2021-11-30 4 S $24.00 $3,211 D/D (131) 92,499     -
   Smith Scott Andrew President   •       •      –    2021-11-30 4 S $24.00 $11,715 D/D (478) 349,268     -
   Vasquez Christian See Remarks   •       –      –    2021-11-30 4 S $24.00 $18,822 D/D (768) 26,470     -
  207 Records found
  1  2  3  4  5  6  7  8  9   
  Page 6 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us